Stocks · Health care · Pharmaceutical Preparations

iBio, Inc.

IBIO Clue Score37
United States Fiscal year ends June CIK 0001420720 Results filed 28 Aug 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Marc Banjak
26 Mar 2026
Chief Legal Officer
Buy
1,434
$1.76
$2.52K
Marc Banjak
26 Mar 2026
Chief Legal Officer
Buy
12,500
$1.64
$20.53K
Martin Brenner
19 Mar 2026
See Remarks
Buy
12,336
$2.02
$24.92K
Felipe Duran
19 Mar 2026
Chief Financial Officer
Buy
24,835
$2.02
$50.13K
Gary Sender
10 Jan 2025
Director
Buy
9,191
$2.72
$25.00K
Antonio Bernardino Guimaraes Parada
10 Jan 2025
Director
Buy indirect
183,823
$2.72
$500.00K
William D Clark
10 Jan 2025
Director
Buy
1,838
$2.72
$5.00K
David Arkowitz
10 Jan 2025
Director
Buy
18,382
$2.72
$50.00K
Marc Banjak
10 Jan 2025
Chief Legal Officer
Buy
9,191
$2.72
$25.00K
Martin Brenner
10 Jan 2025
See Remarks
Buy
9,191
$2.72
$25.00K
Felipe Duran
10 Jan 2025
Chief Financial Officer
Buy
9,191
$2.72
$25.00K
Martin Brenner
1 Nov 2023
See Remarks
Sell
4,881
$0.27
$1.30K
Martin Brenner
3 Oct 2023
See Remarks
Sell
5,267
$0.30
$1.59K
Martin Brenner
2 Oct 2023
See Remarks
Sell
4,215
$0.31
$1.31K
Martin Brenner
28 Aug 2023
See Remarks
Sell
5,011
$0.31
$1.53K
Martin Brenner
27 Jul 2023
See Remarks
Sell
35
$0.51
$17.85
Martin Brenner
27 Jul 2023
See Remarks
Sell
4,480
$0.51
$2.29K
Martin Brenner
12 Jul 2023
See Remarks
Sell
47,020
$0.59
$27.52K
Martin Brenner
21 Jun 2023
See Remarks
Sell
100
$0.68
$68.32
Martin Brenner
21 Jun 2023
See Remarks
Sell
225
$0.69
$154.51
Martin Brenner
21 Jun 2023
See Remarks
Sell
3,859
$0.68
$2.63K
Martin Brenner
22 May 2023
See Remarks
Sell
24
$0.95
$22.68
Martin Brenner
22 May 2023
See Remarks
Sell
4,158
$0.94
$3.89K
Martin Brenner
24 Apr 2023
See Remarks
Sell
4,382
$1.20
$5.26K
Martin Brenner
23 Mar 2023
See Remarks
Sell
5,213
$2.13
$11.11K
Martin Brenner
21 Feb 2023
See Remarks
Sell
3,976
$1.77
$7.04K
Robert Matthew Lutz
10 Mar 2022
See Remarks
Sell
24,625
$0.35
$8.51K
Randy Joe Maddux
7 Dec 2021
Chief Operating Officer
Sell
37,243
$0.68
$25.44K
Eastern Capital LTD
11 Aug 2020
10% owner
Sell
15,864,436
$2.92
$46.33M
Eastern Capital LTD
10 Aug 2020
10% owner
Sell
7,264,864
$3.91
$28.43M
Eastern Capital LTD
7 Aug 2020
10% owner
Sold after exercise
1,355,604
$3.83
$5.19M
Eastern Capital LTD
6 Aug 2020
10% owner
Sell
2,768,137
$4.18
$11.57M
Eastern Capital LTD
5 Aug 2020
10% owner
Sell
900,000
$4.46
$4.01M
Eastern Capital LTD
4 Aug 2020
10% owner
Sell
600,000
$4.39
$2.64M
Robert L Erwin
4 Jun 2020
President
Sold after exercise
28,268
$1.71
$48.34K
Robert L Erwin
2 Jun 2020
President
Sold after exercise
96,124
$1.62
$155.72K
James P. Mullaney
27 May 2020
Chief Financial Officer
Sold after exercise
11,250
$1.61
$18.11K
Thomas Francis 3rd Isett
19 Mar 2020
CEO and Executive Co-Chairman
Exercised, kept
100,000
$0.20
$20.00K
Thomas Francis 3rd Isett
17 Mar 2020
CEO and Executive Co-Chairman
Exercised, kept
78,024
$0.22
$17.17K
Eastern Capital LTD
12 Jul 2018
10% owner
Buy
2,200,000
$0.90
$1.98M
Eastern Capital LTD
26 Jun 2018
10% owner
Buy
1,683,334
$0.90
$1.52M
Eastern Capital LTD
30 Nov 2017
10% owner
Buy
12,000,000
$0.20
$2.40M
Kenneth Bryan Dart
23 Feb 2017
10% owner
Buy indirect
1
—
no price

What was left out

Form 4 filings counted 139
Amendments (4/A) skipped 5
Filings about a different issuer 0
Unreadable filings 0
Joint filings 5
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 4
Sales at will 22
Transactions with no price 1
Shares from compensation/vesting 30,466,215
Sales filed before the plan box existed 8
History held since 21 Aug 2008